References
- Alimoghaddam K, Mosavi-Jarrahi A, Malekzadeh R, Parkin M (2009). Cancer incidence in Tehran metropolis: The first report from the Tehran population-based cancer registry, 1998-2001. Arch Iran Med, 12, 15-23
- Alimoghaddam K, Jalali A, Sharifi Aliabadi L, et al (2014). The outcomes of esophageal and gastric cancer treatments in a retrospective study, single center experience. IJHOSCR, 8, 9-13.
- Atrkar-Roushan Z, Kazemnejad A, Mansour-Ghanaei F, Zayeri F (2013). Trend analysis of gastrointestinal cancer incidences in Guilan province: comparing rates over 15 years. Asian Pac J Cancer Prev, 14, 7587-93. https://doi.org/10.7314/APJCP.2013.14.12.7587
- Babaei M, Mousavi S, Malek M, et al (2005). Cancer occurrence in Semnan province, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev, 6, 159-64.
- Babu GR, Samari G, Cohen SP, et al (2011). Breast cancer screening among females in Iran and recommendations for improved practice: a review. Asian Pac J Cancer Prev, 12, 1647-55.
- Fateh M, Emamian MH (2013). Cancer incidence and trend analysis in Shahroud, Iran, 2000- 2010. Iran J Cancer Prev, 2, 85-94
- Harirchi I, Kolahdoozan S, Hajizadeh S, et al (2014). Esophageal cancer in Iran: a population-based study regarding adequacy of cancer surgery and overall survival. Eur J Surg Oncol, 40, 352-7. https://doi.org/10.1016/j.ejso.2013.10.011
- Kaviani A, Neishaboury MR, Mohammadzadeh N, Ansari-Damavandi M, Jamei K (2013). Effects of obesity on presentation of breast cancer, lymph node metastasis and patient survival: A retrospective review. Asian Pac J Cancer Prev, 15, 2225-9. https://doi.org/10.7314/APJCP.2013.14.4.2225
- Kolahdoozan S, Sajadi A, Radmard AR, Khademi H (2010). Five common cancers in Iran. Arch Iran Med, 13, 143-6.
- Mashhadi MA, Nezam K, Abdollahinejad MJ (2009). Gastric cancer in South East of Iran. IJHOSCR, 3, 38-42.
- Najafi F, Mozaffari HR, Karami M, et al (2011). Trends in incidence of gastrointestinal tract cancers in Western Iran, 1993-2007. Iran Red Crescent Med J, 13, 805-10.
- Rahimi Z, Merat A, Gerard N, Krishnamoorthy R, Nagel RL (2006). Implications of the genetic epidemiology of globin haplotypes linked to the sickle gene in Southern Iran. Hum Biol, 78, 719-31. https://doi.org/10.1353/hub.2007.0016
- Roshandel G, Sadjadi A, Aarabi M, et al (2012). Cancer incidence in Golestan province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. Arch Iran Med, 15, 196-200.
- Salehi A, Khezri A, Malekmakan L, Aminsharifi A (2011). Epidemiologic status of bladder cancer in Shiraz, Southern Iran. Asian Pac J Cancer Prev, 12, 1323-7.
- Somi MH, Farhang S, Mirinezhad SK, et al (2008). Cancer in East Azerbaijan, Iran: results of a population-based cancer registry. Asian Pac J Cancer Prev, 9, 327-30.
- Tahmasby B, MarnaniAB, Maleki M, et al (2013). Blood malignancies in Mazandaran province of Iran. Asian Pac J Cancer Prev, 14, 1053-6. https://doi.org/10.7314/APJCP.2013.14.2.1053
- Talaiezadeh A, Tabesh H, Sattari A, Ebrahimi S (2013). Cancer incidence in Southwest of Iran: first report from Khuzestan population-based cancer registry, 2002-2009. Asian Pac J Cancer Prev, 14, 7517-22. https://doi.org/10.7314/APJCP.2013.14.12.7517
- Yari K, Rahimi Z, Moradi MR, Rahimi Z (2014). The MMP-2-735 C allele is a risk factor for susceptibility to breast cancer. Asian Pac J Cancer Prev, 15, 6199-203. https://doi.org/10.7314/APJCP.2014.15.15.6199
- Yavari P, Sadrolhefazi B, Mohagheghi MA, Mehrazin R (2009). A descriptive retrospective study of bladder cancer at a hospital in Iran (1973-2003). Asian Pac J Cancer Prev, 10, 681-4.
Cited by
- iRGD as a tumor-penetrating peptide for cancer therapy vol.15, pp.5, 2017, https://doi.org/10.3892/mmr.2017.6419
- The GPX1 Pro198Leu polymorphism in gastric cancer patients with and without Helicobacter pylori infection vol.39, pp.11, 2017, https://doi.org/10.1007/s13258-017-0594-8